Erectile Dysfunction Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Erectile Dysfunction stocks.

Erectile Dysfunction Stocks Recent News

Date Stock Title
Apr 19 LLY Weight loss drugs and the many use cases in medical treatments
Apr 19 LLY Eli Lilly Shares Show Healthy Rise
Apr 19 LLY Pharma Stock Roundup: JNJ's Q1 Results, LLY, ABBV, RHHBY's Successful Study Data
Apr 19 PFE Unveiling Pfizer's Potent Cocktail: Key Drivers Of Free Cash Flow Growth
Apr 18 LLY 13 Best Low Volatility Stocks to Buy According to Hedge Funds
Apr 18 LLY Patients Find Weight Loss Drug Zepbound A Game Changer, But Makers See Production Delay Until 2025
Apr 18 LLY India's Biocon developing its own version of Wegovy, clinical trial likely next year
Apr 18 LLY How The Weight-Loss Bonanza Prompted A ResMed Sell-Off — But Could Soon Drive Shares Higher
Apr 18 PFE If You'd Invested $1,000 in Pfizer 5 Years Ago, Here's How Much You'd Have Today
Apr 18 LLY Company News for Apr 18, 2024
Apr 18 LLY Eli Lilly's (LLY) Tirzepatide Meets Goals in Sleep Apnea Studies
Apr 18 LLY 14 Best Large Cap Dividend Growth Stocks To Buy Now
Apr 18 LLY 2 Growth Stocks That Turned $10,000 Into More Than $100,000 in Just 10 Years
Apr 18 LLY The Zacks Analyst Blog Highlights Eli Lilly, Linde, Caterpillar, Salesforce, and Wells Fargo
Apr 18 LLY Metsera, a well-funded obesity drug startup, sees chance to challenge Lilly, Novo
Apr 17 LLY Why Eli Lilly Stock Beat the Market Today While ResMed and AdaptHealth Sank
Apr 17 LLY Top Research Reports for Eli Lilly, Linde & Caterpillar
Apr 17 LLY Stocks Fall After Fed Data; Nvidia Tests Key Level While Tesla's Musk Faces Shareholder Vote
Apr 17 PFE Pfizer-Connect Biopharma deal for anti-inflammatory agent ends
Apr 17 LLY Eli Lilly's Mounjaro, Zepbound to remain in shortage through end of Q2
Erectile Dysfunction

Erectile dysfunction (ED), also known as impotence, is a type of sexual dysfunction characterized by the inability to develop or maintain an erection of the penis during sexual activity. Erectile dysfunction can have psychological consequences as it can be tied to relationship difficulties and self-image.
A physical cause can be identified in about 80% of cases. These include cardiovascular disease, diabetes mellitus, neurological problems such as following prostatectomy, hypogonadism, and drug side effects. Psychological impotence is where erection or penetration fails due to thoughts or feelings; this is somewhat less frequent, in the order of about 10% of cases. In psychological impotence, there is a strong response to placebo treatment.
Treatment involves addressing the underlying causes, lifestyle modifications, and addressing psychosocial issues. In many cases, a trial of pharmacological therapy with a PDE5 inhibitor, such as sildenafil, can be attempted. In some cases, treatment can involve inserting prostaglandin tablets into the urethra, injecting smooth muscle relaxants and vasodilators into the penis, a penile prosthesis, a penis pump, or vascular reconstructive surgery. It is the most common sexual problem in men.

Browse All Tags